BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22696667)

  • 1. Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman.
    Chantler DJ; Gordon D; Millan D; Panarelli M
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral microscopic Leydig cell ovarian tumors in the postmenopausal woman.
    Langevin TL; Maynard K; Dewan A
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
    Ferrinho C; Silva E; Oliveira M; Sequeira Duarte J
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33731391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A virilizing Leydig cell tumor of the ovary associated with stromal hyperplasia under gonadotropin control.
    Marcondes JA; Nery M; Mendonça BB; Hayashida SA; Halbe HW; Carvalho FM; Wajchenberg BL
    J Endocrinol Invest; 1997 Dec; 20(11):685-9. PubMed ID: 9492110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leydig cell tumor as a cause of hirsutism in a postmenopausal woman].
    Matuszczyk A; Petersenn S; Lahner H; Haude M; Veit P; Becker JU; Kimmig R; Bockisch A; Mann K
    Med Klin (Munich); 2007 Mar; 102(3):259-62. PubMed ID: 17345023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman.
    Marcondes JA; Curi DD; Matsuzaki CN; Barcellos CR; Rocha MP; Hayashida SA; Baracat EC
    Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1184-8. PubMed ID: 19082308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leydig cell tumor in the post-menopausal woman: case report and literature review.
    Sherf S; Martinez D
    Acta Biomed; 2016 Jan; 87(3):310-313. PubMed ID: 28112699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virilizing ovarian Leydig cell tumor in a woman with subclinical Cushing syndrome.
    Diab DL; Faiman C; Siperstein AE; Grossman WF; Rabinowitz LO; Hamrahian AH
    Endocr Pract; 2008 Apr; 14(3):358-61. PubMed ID: 18463044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
    Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia and hirsutism in a postmenopausal woman as the presenting complaint of ovarian hilus (Leydig) cell tumor.
    Berbegal L; Albares MP; De-Leon FJ; Negueruela G
    Actas Dermosifiliogr; 2015 Oct; 106(8):676-8. PubMed ID: 25910403
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
    Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
    Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic removal of virilizing hilar cell tumor in a postmenopausal patient.
    Silva PD; Sorensen ML; Reynertson R; Virata RL; Mahairas GH
    J Am Assoc Gynecol Laparosc; 1997 Aug; 4(4):499-502. PubMed ID: 9224588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual steroid-producing ovarian tumour: case report.
    Stephens JW; Katz JR; McDermott N; MacLean AB; Bouloux PM
    Hum Reprod; 2002 Jun; 17(6):1468-71. PubMed ID: 12042263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV; Loughlin J; Shapiro SS
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
    Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
    Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
    Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
    Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
    Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
    Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.